INVO Fertility Files 8-K: Material Agreement, Equity Sales
Ticker: IVF · Form: 8-K · Filed: Dec 5, 2025 · CIK: 1417926
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
TL;DR
INVO Fertility signed a big deal and sold some stock on Dec 2nd.
AI Summary
On December 2, 2025, INVO Fertility, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other events. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity, including a new material agreement and equity transactions, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing details a material definitive agreement and unregistered equity sales, which can introduce financial and operational risks.
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- December 2, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 001-39701 (commission_file_number) — SEC File Number
- 20-4036208 (ein) — EIN
FAQ
What type of material definitive agreement did INVO Fertility, Inc. enter into?
The filing states that INVO Fertility, Inc. entered into a 'Material Definitive Agreement' but does not specify the nature of the agreement in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on December 2, 2025.
What is the state of incorporation for INVO Fertility, Inc.?
INVO Fertility, Inc. is incorporated in Nevada.
What is the SEC file number for INVO Fertility, Inc.?
The SEC file number for INVO Fertility, Inc. is 001-39701.
Does the filing provide details on the unregistered sales of equity securities?
The filing mentions 'Unregistered Sales of Equity Securities' as an item information, but the specific details of these sales are not included in the provided text.
Filing Stats: 1,425 words · 6 min read · ~5 pages · Grade level 12.8 · Accepted 2025-12-05 17:01:22
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value IVF The Nasdaq Stock Mark
- $4,000,000 — n the aggregate amount of approximately $4,000,000, comprised of 235,000 shares (the "Shar
- $1.69 — y of such date, at an exercise price of $1.69 per share of Common Stock, subject to a
- $300,000 — he Company intends to utilize (i) up to $300,000 of the net proceeds to fund the purchas
- $75,000 — for Family Beginnings, P.C., (ii) up to $75,000 towards expenses related to the purchas
- $938,000 — of Family Beginning, P.C., (iii) up to $938,000 towards outstanding debt obligations th
- $2.1125 — of Common Stock at an exercise price of $2.1125 per share (the "Placement Agent Warrant
- $50,000 — r certain expenses and legal fees up to $50,000. Further, in connection with the Priv
Filing Documents
- form8-k.htm (8-K) — 51KB
- ex1-1.htm (EX-1.1) — 87KB
- ex4-1.htm (EX-4.1) — 112KB
- ex4-2.htm (EX-4.2) — 120KB
- ex4-3.htm (EX-4.3) — 132KB
- ex10-1.htm (EX-10.1) — 261KB
- ex10-2.htm (EX-10.2) — 190KB
- ex99-1.htm (EX-99.1) — 15KB
- 0001493152-25-026427.txt ( ) — 1327KB
- ivf-20251202.xsd (EX-101.SCH) — 3KB
- ivf-20251202_lab.xml (EX-101.LAB) — 33KB
- ivf-20251202_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 5, 2025 INVO FERTILITY, INC. /s/ Steven Shum Steven Shum Chief Executive Officer -4-